Strides Pharma schedules earnings call for October 30, 2026

Board & Shareholder Meetings View source PDF Explain this filing

STAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.8%Reaction day

₹1001.10

prior close

₹1006.50

announcement price

After-mkt

timing

Nifty Microcap 250market+0.4%+2.4% vs market

Pharmaceuticals peers, median of 174sector+1.2%+1.6% vs sector

On the reaction day the stock moved 2.4 pts more than Nifty Microcap 250 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.2

10m

+1.5

15m

+2.1

30m

+2.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.8+0.4+2.4+1.2+1.6

Next day

+8.5+2.1+6.4+3.1+5.4

+8.5pendingpending+4.7+3.8

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Strides Pharma Science Limited has scheduled an investor and analyst earnings call for Friday, October 30, 2026, at 10:00 am IST. Management will discuss the company's unaudited financial results for the quarter and half year ended September 30, 2026. Managing Director and Group CEO Badree Komandur and Group CFO Vikesh Kumar will participate. No financial figures are included in this filing.

Likely market impact

The filing has no direct earnings impact. The call may provide performance and outlook updates that could affect investor sentiment and the stock.